首页> 外文OA文献 >Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2
【2h】

Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2

机译:前列腺素D2对痛觉敏引起的痛觉过敏小鼠的抑制作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We recently showed that intrathecal administration of nociceptin induced allodynia by innocuous tactile stimuli and hyperalgesia by noxious thermal stimuli in conscious mice. In the present study, we examined the effect of prostaglandins on nociceptin-induced allodynia and hyperalgesia.Prostaglandin D2 (PGD2) blocked the allodynia induced by nociceptin in a dose-dependent manner with an IC50 of 26 ng kg−1, but did not affect the nociceptin-induced hyperalgesia at doses up to 500 ng kg−1. BW 245C (an agonist for PGD (DP) receptor) blocked the allodynia with an IC50 of 83 ng kg−1.The blockade of nociceptin-induced allodynia by PGD2 was reversed by the potent and selective DP-receptor antagonist BW A868C in a dose-dependent manner with an ED50 of 42.8 ng kg−1.Glycine (500 ng kg−1) almost completely blocked the nociceptin-induced allodynia. A synergistic effect on the inhibition of nociceptin-evoked allodynia was observed between glycine and PGD2 at below effective doses.Dibutyryl cyclic AMP, but not dibutyryl cyclic GMP, blocked the nociceptin-induced allodynia with an IC50 of 2.9 μg kg−1.PGE2, PGF2α, butaprost (an EP2 agonist) and cicaprost (a PGI receptor agonist) did not affect the nociceptin-induced allodynia.These results demonstrate that PGD2 inhibits the nociceptin-evoked allodynia through DP receptors in the spinal cord and that glycine may be involved in this inhibition.
机译:我们最近显示鞘内注射伤害感受肽通过无害的触觉刺激诱发异常性疼痛,并通过有毒的热刺激引起痛觉过敏。在本研究中,我们研究了前列腺素对痛觉敏敏引起的痛觉过敏和痛觉过敏的作用。前列腺素D2(PGD2)以剂量依赖性方式阻断痛敏敏引起的痛觉过敏,IC50为26 ng kg-1,但没有影响伤害感受肽诱导的痛觉过敏,剂量最高可达500µng kg-1。 BW 245C(PGD(DP)受体激动剂)阻断异常性疼痛,IC50为83 ng kg-1。有效且选择性的DP受体拮抗剂BW A868C逆转了PGD2对痛觉肽诱导的异常性疼痛的阻断作用。依赖方式,ED50为42.8 ng·kg-1。甘氨酸(500 ng·kg-1)几乎完全阻断了痛敏肽诱发的异常性疼痛。在低于有效剂量时,甘氨酸和PGD2之间可观察到协同抑制痛觉激肽诱发的异常性疼痛。二丁酰环AMP而非二丁酰环GMP阻断了伤害感受肽诱导的异常性疼痛,IC50为2.9μgkg-1.PGE2, PGF2α,butaprost(一种EP2激动剂)和cicaprost(一种PGI受体激动剂)没有影响伤害感受肽引起的异常性疼痛。这些结果表明PGD2通过脊髓中的DP受体抑制伤害感受性引起的异常性疼痛,并且甘氨酸可能参与其中这种抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号